MSB 3.50% $1.33 mesoblast limited

MESO Nasdaq update, page-2121

  1. 6,376 Posts.
    lightbulb Created with Sketch. 379
    Before vaccination, recoveries were considered the 'good metric' of COVID. Someone might look at their state's dashboard or a local paper, see a number of recovered patients, and think that indicates a triumphant victory over a deadly disease.
    In fact, COVID recovery is far more complicated. There is no standard definition of what makes someone 'recovered' from the disease, and even then, recovery will look different for every patient.
    One person may have mild symptoms, then feel back to normal within two weeks  while another may suffer from ongoing exhaustion and mental fog for months.
    Patients in the latter category have come to be called 'long-haulers,' facing a condition called long COVID. Recent studies have estimated that one in four COVID patients will become long COVID patients.
    A recent study from Michigan Medicine, The new study, pub
      
    Here's some more of the article basically supporting what we already know I guess.....I tried to post the rest of the article but I wasn't allowed because of the photos & graphs !!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.33
Change
0.045(3.50%)
Mkt cap ! $1.518B
Open High Low Value Volume
$1.30 $1.35 $1.30 $2.885M 2.183M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 7070 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.